DCAT Week 2026 is a leading global meeting for the pharmaceutical manufacturing value chain. Organized by DCAT, it occurs in New York City each March. Senior executives from pharma companies and key development, manufacturing, sourcing, and supply partners meet there for interdisciplinary exchange.
Let’s talk on CDMO solutions and clinical supplies during DCAT: Book time to meet with Philippe
DCAT Week facilitates strategic meetings among innovator pharma, generic manufacturers, contract service providers, technology developers, and suppliers. In 2026, the event will let industry leaders discuss market trends, form partnerships, negotiate supply agreements, and explore emerging technologies shaping drug development and commercialization.
The event covers topics like global supply chains, advanced manufacturing, sourcing strategies, drug substance and product innovation, biologics, cell and gene therapies, sustainability, digital transformation, regulatory updates, and portfolio management. These subjects appear in keynotes, educational programs, networking events, and private business meetings across Midtown Manhattan.
Attendees include C-suite executives, procurement directors, supply-chain strategists, R&D and technical leaders, business development managers, and regulatory specialists from major pharma companies, CDMOs, CMOs, API manufacturers, excipient suppliers, technology providers, packaging firms, and logistics companies. This exclusive environment enables meaningful interactions, making it one of the industry’s most valuable annual gatherings.
DCAT 2026 offers companies opportunities to strengthen global partnerships, increase visibility among top buyers. Also take the chance to understand market dynamics, and identify innovations that improve manufacturing and supply reliability. Its concentration of industry leaders in one city creates an unmatched platform for strategic collaboration and competitive intelligence.
